From ImmuCell's results release of 2026年11月13日; its quarterly report has since been filed.

• Revenue

  Actual

  $8M

  +46% y/y ↑
  +12% q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  $0.10

  -50% q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  $957.8K

  -51% q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.